Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
16.05.2025 08:31:03

EQS-News: Redcare Pharmacy's Annual General Meeting 2025: All agenda items approved; Michael Köhler and Stephan Weber new members of the Supervisory Board.

EQS-News: Redcare Pharmacy N.V. / Key word(s): AGM/EGM
Redcare Pharmacy's Annual General Meeting 2025: All agenda items approved; Michael Köhler and Stephan Weber new members of the Supervisory Board.

16.05.2025 / 08:31 CET/CEST
The issuer is solely responsible for the content of this announcement.


Redcare Pharmacy's Annual General Meeting 2025: All agenda items approved; Michael Köhler and Stephan Weber new members of the Supervisory Board.
 

Sevenum, the Netherlands, 16 May, 2025. At Redcare Pharmacy’s Annual General Meeting held yesterday, shareholders voted with an absolute majority for all agenda items, among others the appointment of Michael Köhler and Stephan Weber as new members of the Supervisory Board.

Björn Söder, Chairman of the Supervisory Board, expresses satisfaction with the investors’ approval stating: "We are very delighted that our shareholders approved the appointments of Michael and Stephan. Both embody true entrepreneurial spirit and bring considerable industry knowledge to the Supervisory Board. They will be invaluable assets as we continue to advance our long-term strategy.”  

Furthermore, the re-appointment of Jérôme Cochet as a member of the Supervisory Board for an additional and final term of one year was also approved. The Supervisory Board now consists of Björn Söder (Chairman), Jaska de Bakker (Deputy Chairwoman), Jérôme Cochet, Michael Köhler and Stephan Weber.

More information on the resolutions, including detailed voting results, can be found on Redcare Pharmacy’s corporate website in the Investor Relations section.
 

Investor Relations Contact:
Monica Ambrosi (Associate Director, Investor Relations)
investors@redcare-pharmacy.com

 Press Contact:
Sven Schirmer (Director, Corporate Communications)
press@redcare-pharmacy.com 

 

About Redcare Pharmacy.

Originally founded in 2001, Redcare Pharmacy N.V. (formerly known as Shop Apotheke Europe N.V.) today is the leading e-pharmacy in Europe, currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in Sevenum, close to the Dutch city of Venlo and in the heart of Europe, the company has locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven.

As the one-stop pharmacy of the future, Redcare Pharmacy offers over 13 million active customers a wide range of more than 250,000 products at attractive and fair prices. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands.

Pharmaceutical safety is of top priority. Being a pharmacy at its core, Redcare stands for comprehensive pharmaceutical consultation service. Since care is at the heart of everything Redcare does, the company provides services for all stages of life and health. This ranges from its marketplaces to unique delivery options and medication management.

Redcare Pharmacy N.V. has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016. As of 19 June 2023, the company is a member of the MDAX selection index.



16.05.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: investors@redcare-pharmacy.com
Internet: www.redcare-pharmacy.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y072
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2139028

 
End of News EQS News Service

2139028  16.05.2025 CET/CEST

Analysen zu Redcare Pharmacy (ex Shop Apotheke)

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
07.05.25 Redcare Pharmacy Buy Hauck Aufhäuser Lampe Privatbank AG
07.05.25 Redcare Pharmacy Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
06.05.25 Redcare Pharmacy Buy Baader Bank
06.05.25 Redcare Pharmacy Sell UBS AG
06.05.25 Redcare Pharmacy Buy Jefferies & Company Inc.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Zins-Wahnsinn 2025: Europa senkt, USA zögert – Invest 2025 mit Thomas Gitzel

Live von der Invest mit Thomas Gitzel, Chefvolkswirt der VP Bank

Wie entwickelt sich die Zinspolitik in der Schweiz, Europa und den USA? Welche Rolle spielt die Inflation und was bedeutet das für Anlegerinnen und Anleger? Im exklusiven Interview spricht Thomas Gitzel live von der Invest 2025 in Stuttgart über:

🔹 Die aktuelle Zinssituation in der Schweiz
🔹 Die geldpolitische Strategie der Schweizerischen Nationalbank (SNB)
🔹 Zinsentwicklung & Inflation in der Eurozone
🔹 Herausforderungen für die EZB
🔹 Zinspolitik der US-Notenbank Fed unter politischem Druck
🔹 Auswirkungen auf den US-Dollar & Anlegerverhalten
🔹 Persönliche Eindrücke von der Invest 2025

Ein Muss für alle, die Geldpolitik verstehen und Anlageentscheidungen fundiert treffen möchten!

👉🏽 Jetzt auch auf BXplus anmelden und von exklusiven Inhalten rund um Investment & Trading profitieren!

Zins-Wahnsinn 2025: Europa senkt, USA zögert – Invest 2025 mit Thomas Gitzel

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’661.38 19.85 BC8S1U
Short 12’924.13 13.95 SS4MTU
Short 13’431.35 8.85 JZUBSU
SMI-Kurs: 12’335.09 16.05.2025 17:31:03
Long 11’664.85 18.50 BNOSPU
Long 11’428.84 13.72 BH2SIU
Long 10’923.29 8.78 BQFSFU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}